GSK ROE - Return on Equity 2010-2025 | GSK
- GSK average return on equity for 2024 was 26.04, a 70.76% decline from 2023.
- GSK average return on equity for 2023 was 89.05, a 76.27% decline from 2022.
- GSK average return on equity for 2022 was 50.52, a 129.64% increase from 2021.
Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.